US to Reclassify Cannabis in Dramatic Shift in Drug Policy. Here’s Why.
The U.S. Drug Enforcement Agency announced in late April 2024 that it plans to ease federal restrictions on cannabis, reclassifying it from a Schedule I drug to the less restricted Schedule III, whic…